Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
~ Strong PEDMARK® Commercial Momentum Building in 2023 with Broad Payor and Medicaid Coverage ~ ~ PEDMARK® Permanent J-Code Effective April 1, 2023 ~ ~ Recent Positive CHMP Opinion in EU... | May 11, 2023
Source: marketscreener.com